Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Efficacy and safety of omega-3 fatty acids for the prevention of atrial fibrillation: a meta-analysis.

He Z, Yang L, Tian J, Yang K, Wu J, Yao Y.

Can J Cardiol. 2013 Feb;29(2):196-203. doi: 10.1016/j.cjca.2012.03.019. Epub 2012 Jun 7. Review.

PMID:
22681963
2.

Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis.

Costanzo S, di Niro V, Di Castelnuovo A, Gianfagna F, Donati MB, de Gaetano G, Iacoviello L.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):906-11. doi: 10.1016/j.jtcvs.2013.03.015. Epub 2013 Apr 12. Review.

3.

Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.

Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC; GESICA Investigators.

J Am Coll Cardiol. 2013 Jan 29;61(4):463-8. doi: 10.1016/j.jacc.2012.11.021. Epub 2012 Dec 19.

4.

Omega-3 fatty acids in the prevention of atrial fibrillation recurrences after cardioversion: a meta-analysis of randomized controlled trials.

Cao H, Wang X, Huang H, Ying SZ, Gu YW, Wang T, Huang CX.

Intern Med. 2012;51(18):2503-8. Epub 2012 Sep 15. Review.

5.

Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.

Saravanan P, Bridgewater B, West AL, O'Neill SC, Calder PC, Davidson NC.

Circ Arrhythm Electrophysiol. 2010 Feb;3(1):46-53. doi: 10.1161/CIRCEP.109.899633. Epub 2009 Dec 30.

6.

Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study.

Heidt MC, Vician M, Stracke SK, Stadlbauer T, Grebe MT, Boening A, Vogt PR, Erdogan A.

Thorac Cardiovasc Surg. 2009 Aug;57(5):276-80. doi: 10.1055/s-0029-1185301. Epub 2009 Jul 23.

PMID:
19629889
7.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

8.

A meta-analysis of omega-3 fatty acids and incidence of atrial fibrillation.

Khawaja O, Gaziano JM, Djoussé L.

J Am Coll Nutr. 2012 Feb;31(1):4-13. Review.

PMID:
22661621
9.

Omega-3 fatty acids for postoperative atrial fibrillation: alone or in combination with antioxidant vitamins?

Guo XY, Yan XL, Chen YW, Tang RB, Du X, Dong JZ, Ma CS.

Heart Lung Circ. 2014 Aug;23(8):743-50. doi: 10.1016/j.hlc.2014.02.018. Epub 2014 Mar 12. Review.

PMID:
24685324
10.

N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.

Calò L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M.

J Am Coll Cardiol. 2005 May 17;45(10):1723-8.

11.

Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.

Wang Z, Zhang Y, Gao M, Wang J, Wang Q, Wang X, Su L, Hou Y.

Pharmacotherapy. 2011 Nov;31(11):1051-62. doi: 10.1592/phco.31.11.1051.

PMID:
22026393
12.

Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials.

Zhang B, Zhen Y, Tao A, Bao Z, Zhang G.

J Cardiol. 2014 Jan;63(1):53-9. doi: 10.1016/j.jjcc.2013.06.014. Epub 2013 Aug 1.

13.

N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials.

Mariani J, Doval HC, Nul D, Varini S, Grancelli H, Ferrante D, Tognoni G, Macchia A.

J Am Heart Assoc. 2013 Feb 19;2(1):e005033. doi: 10.1161/JAHA.112.005033. Review.

14.

The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation.

Macchia A, Varini S, Grancelli H, Nul D, Laffaye N, Ferrante D, Tognoni G, Doval HC; FORomegaARD investigators.

Am Heart J. 2009 Mar;157(3):423-7. doi: 10.1016/j.ahj.2008.10.027. Epub 2009 Jan 8.

PMID:
19249410
15.

Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs.

Sarrazin JF, Comeau G, Daleau P, Kingma J, Plante I, Fournier D, Molin F.

J Am Coll Cardiol. 2007 Oct 9;50(15):1505-12. Epub 2007 Sep 24.

16.

n-3 Polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials.

Benedetto U, Angeloni E, Melina G, Danesi TH, Di Bartolomeo R, Lechiancole A, Refice S, Roscitano A, Comito C, Sinatra R.

J Cardiovasc Med (Hagerstown). 2013 Feb;14(2):104-9. doi: 10.2459/JCM.0b013e32834a13c1. Review.

PMID:
21826019
17.

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.

Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ, Latini R, Libby P, Lombardi F, O'Gara PT, Page RL, Tavazzi L, Tognoni G; OPERA Investigators.

JAMA. 2012 Nov 21;308(19):2001-11. Erratum in: JAMA. 2013 Mar 6;309(9):876.

18.

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

Savelieva I, Kakouros N, Kourliouros A, Camm AJ.

Europace. 2011 Mar;13(3):308-28. doi: 10.1093/europace/eur002. Review.

PMID:
21345926
19.

The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials.

Yang Q, Qi X, Li Y.

BMC Cardiovasc Disord. 2014 Aug 13;14:99. doi: 10.1186/1471-2261-14-99. Review.

20.

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.

Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM.

JAMA. 2010 Dec 1;304(21):2363-72. doi: 10.1001/jama.2010.1735. Epub 2010 Nov 15.

PMID:
21078810

Supplemental Content

Support Center